< Back to the Blog

About the author

Dr Mary Parman
Dr. Mary Parman is an OB/GYN with nearly 20 years of experience and a leading voice at the intersection of clinical care and women’s health technology.

Sources

  1. Marjoribanks, J., et al. (2017). Long-term hormone therapy for perimenopausal and postmenopausal women. Cochrane Database of Systematic Reviews, 1, CD004143.
  2. Davis, S.R., et al. (2019). Menopause. Nature Reviews Disease Primers, 5(1), 1–19.
  3. Slopien, R., et al. (2018). Menopause and diabetes: EMAS clinical guide. Maturitas, 117, 6–10.
  4. Lobo, R.A. (2017). Hormone-replacement therapy: current thinking. Nature Reviews Endocrinology, 13(4), 220–231.
  5. Stuenkel, C.A., et al. (2015). Treatment of symptoms of the menopause: an Endocrine Society clinical practice guideline. Journal of Clinical Endocrinology & Metabolism, 100(11), 3975–4011.
  6. Rossouw, J.E., et al. (2002). Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA, 288(3), 321–333.
  7. Crandall, C.J., et al. (2023). Management of menopausal symptoms: a review. JAMA, 329(5), 405–420.
  8. Abdulnour, J., et al. (2012). The effect of the menopausal transition on body composition and cardiometabolic risk factors: a Montreal-Ottawa New Emerging Team group study. Menopause, 19(7), 760–767.

About the Oova Blog:
Our content is developed with a commitment to high editorial standards and reliability. We prioritize referencing reputable sources and sharing where our insights come from. The Oova Blog is intended for informational purposes only and is never a substitute for professional medical advice. Always consult a healthcare provider before making any health decisions.